Compounds > zm 241385
Page last updated: 2024-09-05

zm 241385 and mesopram

zm 241385 has been researched along with mesopram in 1 studies

Compound Research Comparison

Studies
(zm 241385)		Trials
(zm 241385)		Recent Studies (post-2010)
(zm 241385)		Studies
(mesopram)		Trials
(mesopram)		Recent Studies (post-2010) (mesopram)
4013124812

Protein Interaction Comparison

ProteinTaxonomyzm 241385 (IC50)mesopram (IC50)
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.42
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.42
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.42
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.42
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)1.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
French, SW; Khachatoorian, R; Micewicz, ED; Ruchala, P1

Other Studies

1 other study(ies) available for zm 241385 and mesopram

ArticleYear
Identification of novel small-molecule inhibitors of Zika virus infection.
    Bioorganic & medicinal chemistry letters, 2018, 02-01, Volume: 28, Issue:3

    Topics: A549 Cells; Antiviral Agents; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Zika Virus; Zika Virus Infection

2018